| |
| |
|
| Insider
Information: |
Bazemore Robert B |
| Relationship: |
Director |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
327,626 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$526,360 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
327,626 |
|
|
| Total
Value |
$526,360 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Synageva BioPharma Corp |
GEVA |
Chief Operating Officer |
2015-06-22 |
0 |
2014-09-23 |
0 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
President & CEO, Direc... |
2021-03-25 |
322,626 |
2016-08-31 |
0 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-03-30 |
5,000 |
2021-03-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NUVB |
Nuvation Bio Ord Shs Clas... |
Director |
– • – |
2021-03-30 |
4 |
B |
$9.98 |
$49,900 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2021-03-25 |
4 |
AS |
$7.85 |
$81,075 |
D/D |
(10,328) |
322,626 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2021-02-04 |
4 |
AS |
$11.21 |
$43,607 |
D/D |
(3,890) |
331,977 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
87,500 |
335,867 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2021-01-25 |
4 |
AS |
$11.41 |
$69,247 |
D/D |
(6,069) |
248,367 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2020-06-26 |
4 |
AS |
$16.15 |
$77,084 |
D/D |
(4,773) |
250,098 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2020-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
10,500 |
254,871 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2020-06-18 |
4 |
AS |
$22.00 |
$440,000 |
D/D |
(20,000) |
244,371 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2020-06-18 |
4 |
OE |
$8.98 |
$89,800 |
D/D |
10,000 |
264,371 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2020-03-25 |
4 |
AS |
$15.28 |
$50,195 |
D/D |
(3,285) |
254,371 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2020-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
120,393 |
257,656 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2020-03-24 |
4 |
AS |
$0.00 |
$0 |
D/D |
(56,537) |
80,726 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
52,595 |
137,263 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2020-01-27 |
4 |
AS |
$20.44 |
$124,153 |
D/D |
(6,074) |
84,668 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2020-01-24 |
4 |
AS |
$24.62 |
$73,909 |
D/D |
(3,002) |
90,742 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2020-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
8,750 |
93,744 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2019-06-13 |
4 |
AS |
$12.10 |
$25,095 |
D/D |
(2,074) |
84,994 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2019-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
87,068 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2019-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
75,383 |
80,068 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2017-02-28 |
4 |
A |
$6.21 |
$10,613 |
D/D |
1,708 |
3,070 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
President & CEO |
• • – |
2016-08-31 |
4 |
A |
$6.21 |
$8,463 |
D/D |
1,362 |
1,362 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
Chief Operating Officer |
• – – |
2015-06-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(35,000) |
0 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
Chief Operating Officer |
• – – |
2015-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
35,000 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
Chief Operating Officer |
• – – |
2014-09-23 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
